Biotechnology

APRINOIA Therapeutics Established Collaboration on Tau PET Imaging Tracer Development

TAIPEI, Dec. 16, 2020 /PRNewswire/ -- APRINOIA Therapeutics Inc. today announced that they had executed a worldwide non-exclusive licensing agreement for Biogen Inc. (Nasdaq: BIIB) to access APRINOIA's positron emission tomography (PET) imaging tracer,18F-APN-1607, for neurodegenerative diseases....

2020-12-16 08:00 3822

EpiVax Reports Record Year for Immunogenicity Screening Toolkit (ISPRI)

PROVIDENCE, R.I., Dec. 16, 2020 /PRNewswire/ -- EpiVax, Inc. reports a record-breaking year for the "ISPRI" immunogenicity screening toolkit. More pharmaceutical and biotechnology companies signed new and continuing licenses for access to the toolkit in 2020 than ever before in the company's twen...

2020-12-16 02:15 2428

RedHill's Phase 2/3 COVID-19 Candidate Opaganib Reduces ARDS-Related Blood Clotting in Preclinical Model

Acute respiratory distress syndrome (ARDS)-induced thrombosis (blood clotting) may occur in up to one-third of COVID-19 patients requiring ICU admission and is a contributing cause of mortality Opaganib demonstrated reduced thrombosis in a preclinical model of ARDS Opaganib has also been shown t...

2020-12-16 00:42 5122

ADC Therapeutics and Overland Pharma Form Strategic JV to Expand ADC Drugs Development and commercialization in Greater China and Singapore, Advised by MSQ Ventures

NEW YORK, Dec. 15, 2020 /PRNewswire/ -- M.S.Q. Ventures ("MSQ") is pleased to announce that its client, ADC Therapeutics SA (NYSE: ADCT), has successfully entered into an agreement to jointly form a new company, Overland ADCT BioPharma (CY) Limited with Overland Pharmaceuticals, a fully integrate...

2020-12-15 22:00 4629

GenScript and InnoBation Enter into the Agreement for CAR-T therapy

NANJING, China and SEOUL, South Korea, Dec. 15, 2020 /PRNewswire/ -- A global leading biotech company GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) announces that it has reached the agreement for cell line development and engineering, manufacture service of GMP Plasmids and Len...

2020-12-15 15:18 6192

Guardant Health AMEA Wins Frost & Sullivan's Market Leadership Award for Liquid Biopsy in Precision Oncology in Asia, Middle East and Africa

MUMBAI, India, Dec. 15, 2020 /PRNewswire/ -- Guardant Health Asia, Middle East andAfrica (AMEA) has won Frost & Sullivan's 2020 Market Leadership Award for Liquid Biopsy in Precision Oncology in AMEA. This accolade is a testament to the success of the company's flagship liquid biopsy, the Guardan...

2020-12-15 11:00 1884

Regent Pacific Completes Acquisition of Deep Longevity, Inc

* Expands into the emerging field of artificial intelligence (AI) and longevity medicine * Strengthens shareholder mix by adding experienced longevity and wellness biotechnology investors and entrepreneurs HONG KONG, Dec. 15, 2020 /PRNewswire/ --Regent Pacific Group Limited ("Regent Pacific" ...

2020-12-15 02:03 14502

Sai Life Sciences releases its first Sustainability Report

- Developed as per the Global Reporting Initiative (GRI) standards - Highlights the various sustainable choices embraced by the company in steering its journey on a sustainable path HYDERABAD, India, Dec. 14, 2020 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing Contract Resear...

2020-12-14 18:42 2924

Hummingbird Bioscience Announces Collaboration with Tempus to Harness AI-driven Precision Medicine to Accelerate Clinical Development of HMBD-001 In HER3 Driven Cancers

SINGAPORE, Dec. 14, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing revolutionary therapies for hard-to-drug targets, today announced a collaboration with Tempus, a leader in artificial intelligence and precision medicine, to drive t...

2020-12-14 18:00 1902

Molecular Stethoscope Announces Completion and Publication of its Alzheimer's Disease Study in Science Advances

PALO ALTO, Calif., Dec. 14, 2020 /PRNewswire/ -- Molecular Stethoscope, Inc., a precision medicine biotechnology company, announces publication of a human proof-of-concept study for Alzheimer's Disease using its proprietary cell-free messenger RNA (cf-mRNA)-Artificial Intelligence Technology Plat...

2020-12-14 13:00 1501

Accelerating Innovation, Deepening Integration | Viva Biotech Online Investor Day Review

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- Viva Biotech's Online Investor Day was successfully hosted onDecember 8, 2020. The management team conducted an online dialogue with nearly 400 investors, focusing on the company's strategy, personnel plans, technology platforms, integration strategic plans...

2020-12-14 12:15 2781

Catalent Appoints Nakaya Matsumaru as General Manager of its New Clinical Supply Facility in Shiga, Japan

SOMERSET, N.J., Dec. 14, 2020 /PRNewswire/ -- Catalent, the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the appointment of Nakaya "N...

2020-12-14 10:28 5189

Hope Medicine Inc. Announced Dr. Henri Nico Doods as President and Head of Research & Clinical Development

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed') is a global innovative biopharmaceutical company. HopeMed recently announced that the current Chairman of the Scientific Advisory Board, DrHenri Nico Doods, will serve as the company's President, as well as Head of Research & ...

2020-12-14 09:00 7468
1 ... 182183184185186